|
TMX3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.003600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.105900E-02 |
| Normal-vs-Stage2 |
3.391600E-01 |
| Normal-vs-Stage3 |
6.867200E-01 |
| Normal-vs-Stage4 |
5.344600E-01 |
| Stage1-vs-Stage2 |
1.854350E-02 |
| Stage1-vs-Stage3 |
2.240200E-02 |
| Stage1-vs-Stage4 |
5.013600E-01 |
| Stage2-vs-Stage3 |
5.085800E-01 |
| Stage2-vs-Stage4 |
1.857190E-01 |
| Stage3-vs-Stage4 |
3.377400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.958400E-01 |
| Normal-vs-AfricanAmerican |
5.157000E-01 |
| Normal-vs-Asian |
4.800500E-02 |
| Caucasian-vs-AfricanAmerican |
8.967000E-01 |
| Caucasian-vs-Asian |
1.026770E-01 |
| AfricanAmerican-vs-Asian |
3.443000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.449400E-01 |
| Normal-vs-Female |
3.940400E-01 |
| Male-vs-Female |
5.669000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.989600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.449400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.320000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.934600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.380400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.307900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.112400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.749200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.786800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.181000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.590100E-02 |
| Classical-VS-Follicular |
4.612900E-04 |
| Classical-VS-Other |
7.160800E-01 |
| Classical-VS-Normal |
2.617800E-02 |
| Tall-VS-Follicular |
5.974800E-01 |
| Tall-VS-Other |
6.112800E-01 |
| Tall-VS-Normal |
7.877800E-01 |
| Follicular-VS-Other |
4.677600E-01 |
| Follicular-VS-Normal |
2.976600E-01 |
| Other-VS-Normal |
6.540600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.846800E-01 |
| Normal-vs-N1 |
1.709230E-01 |
| N0-vs-N1 |
8.401500E-02 |
|
|
